Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ariad’s new CEO appears focused on cost cuts in first call with investors
Ariad’s new CEO appears focused on cost cuts in first call with investors
Ariad’s new CEO appears focused on cost cuts in first call with investors
Submitted by
admin
on February 24, 2016 - 4:45pm
Source:
Bizjournals.com
News Tags:
Ariad Pharma
Pharma CEOs
Paris Panayiotopoulos
Headline:
Ariad’s new CEO appears focused on cost cuts in first call with investors
Do Not Allow Advertisers to Use My Personal information
